Researchers found that dairy consumption influences gut microbiota composition, with milk promoting beneficial bacteria and ...

A new international study led by scientists from Ben-Gurion University of the Negev has characterized the populations of fat ...

Researchers at the University of Gothenburg have uncovered a critical mechanism that may pave the way for innovative ...

A group of Japanese researchers have found a bacterium that can improve people’s intestinal environment and prevent obesity, raising expectations for the development of novel treatments and preventive ...

Thus, exercise may serve as a rebalancing agent of the gut-microbiota-brain axis under the stimulus of chronic low-grade inflammation induced by obesity. So far, there is little evidence of ...

by considering a broader range of factors related to human health and environmental influences on the microbiota. A healthy microbiome is undoubtedly linked to gut health ... liver diseases, obesity, ...

NHS experts report unprecedented demand for the new generation of obesity treatments. Online pharmacies will no longer be allowed to use customer pictures or questionnaires as evidence.

Objective The assessment of potentially confounding factors affecting colon microbiota composition is essential to the identification of robust microbiome based disease markers. Here, we investigate ...

the researchers identified differences in the gut microbiota and blood metabolites of individuals with a high intake of sugar-sweetened beverages. The altered metabolite profile seen in sugary ...

and obesity, and their relationship to gut microbiota. In the study, high-quality genomes of 1,005 bacterial and 40,135 viral species have been produced, which bolsters the information in the current ...

However, they noted that "how the gut flora and metabolites in the intestinal microenvironment are involved in regulating the preference for sugar is not clear." While these findings are promising ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...